Lorazepam and Uniphyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Uniphyl (theophylline). Common drug interactions include deep vein thrombosis among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Uniphyl. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.



On Jul, 29, 2026

35 people who take Lorazepam and Uniphyl together, and have interactions are studied.

Lorazepam and Uniphyl drug interactions.

What are the common drug interactions of Lorazepam and Uniphyl, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Drug ineffective
  3. Fatigue (feeling of tiredness)
  4. Migraine (headache)
  5. Pharyngeal stenosis (narrowing of the pharyngeal airway)
  6. Pharyngolaryngeal pain
  7. Skin infection
  8. Vision blurred
  9. Aphonia (inability to produce voice)
  10. Discomfort

male:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Pneumonia
  4. Rhinorrhoea (watery mucus discharge from the nose)
  5. Weight increased
  6. Abdominal discomfort
  7. Abdominal pain upper
  8. Anaemia (lack of blood)
  9. Chest discomfort
  10. Cor pulmonale (enlargement of the right ventricle of the heart)

What are the common drug interactions of Lorazepam and Uniphyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Diabetes mellitus inadequate control
  4. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  5. Hyperglycaemia (high blood sugar)
  6. Immunodeficiency
  7. Oral candidiasis (fungal infection of mouth)
  8. Oropharyngeal pain
  9. Pneumonia
  10. Type 2 diabetes mellitus

50-59:

  1. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Dry mouth
  4. Fatigue (feeling of tiredness)
  5. High density lipoprotein decreased
  6. Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood)
  7. Impaired gastric emptying
  8. Ingrowing nail
  9. Lacrimation increased
  10. Migraine (headache)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal distension
  3. Chronic obstructive airways disease
  4. Cor pulmonale (enlargement of the right ventricle of the heart)
  5. Dehydration (dryness resulting from the removal of water)
  6. Delusional disorder, unspecified type
  7. Depression
  8. Diarrhoea
  9. Drug dependence
  10. Drug tolerance increased

What are the existing conditions these people have? *

  1. Pain: 4 people, 11.43%
  2. High Blood Pressure: 3 people, 8.57%
  3. Heart Rate Irregular: 3 people, 8.57%
  4. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 8.57%
  5. Type 2 Diabetes: 2 people, 5.71%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.71%
  7. Immunodeficiency Common Variable: 2 people, 5.71%
  8. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 5.71%
  9. Chronic Obstructive Airways Disease: 2 people, 5.71%
  10. Cardiac Disorder: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Uniphyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lorazepam and Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lorazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lorazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uniphyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and theophylline (the active ingredients of Lorazepam and Uniphyl, respectively), and Lorazepam and Uniphyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: